A phase II study to evaluate the pharmacokinetics, safety, and tolerability of Risperidone ISM multiple intramuscular injections once every 4 weeks in patients with schizophrenia
Sign Up to like & getrecommendations! Published in 2018 at "International Clinical Psychopharmacology"
DOI: 10.1097/yic.0000000000000203
Abstract: This study characterized the pharmacokinetics, safety, and tolerability of Risperidone ISM, a new long-acting intramuscular formulation, for monthly administration without oral supplementation. Patients with schizophrenia received multiple intramuscular injections of 75 mg in the gluteal or… read more here.
Keywords: risperidone ism; study; intramuscular injections; multiple intramuscular ... See more keywords